Food and Drug Regulations
C.04.406 (1) At the beginning of each plasmapheresis session, a physician or physician substitute shall determine if the donor is suitable to participate in plasmapheresis.
(2) If the donor is determined to be temporarily not suitable to participate in plasmapheresis based on the criteria set out in Table 1 or any other medical reason justifying a determination of temporary non-suitability, the fabricator shall cancel the session, inform the donor of the reason why they are temporarily not suitable and indicate the date when the donor may continue to participate in plasmapheresis.
(3) If the donor is determined to be not suitable to participate in plasmapheresis for an indefinite period based on the exclusion criteria set out in Table 2 or any other medical reason justifying a determination of indefinite non-suitability, the fabricator shall cancel the session and inform the donor of the reason why they are not suitable to participate in plasmapheresis for an indefinite period.
TABLE 1
Item Criteria 1 Weight of less than 50 kg 2 Temperature outside of normal limits 3 Blood pressure above 100 mmHg diastolic or 180 mmHg systolic 4 Haemoglobin level of less than 125 g/L of blood or haematocrit value of less than 0.38 L/L of blood 5 Total protein level of less than 60 g/L of blood 6 Substantial blood loss 7 Prior donation of plasma or other blood components 8 Pregnancy 9 History of medical or surgical procedures 10 History of convulsions requiring medical treatment 11 Ability to answer questions compromised by alcohol or drug use 12 Prior transfusion of blood, blood components or a blood product, or prior transplantation of a cell, tissue or organ other than dura mater 13 Skin infection at the site of the phlebotomy 14 Sign or symptom of infection 15 Risk of infection with HIV, hepatitis B virus or hepatitis C virus based on, but not limited to, a history of acupuncture, skin piercing, tattooing, accidental needle-stick injury or occasional sexual relations with a person at risk of having any of those infections 16 Current or past use of medication that poses a risk to a recipient of a product manufactured from source plasma 17 Receipt of a live attenuated vaccine 18 Animal bite requiring prophylaxis for rabies or for which the need for post-exposure prophylaxis has not been assessed TABLE 2
Item Exclusion Criteria 1 Abnormal cardiovascular function or serious or chronic cardiovascular disease 2 Abnormal respiratory function or serious or chronic respiratory disease 3 Bleeding disorder that poses a risk to the donor in relation to plasmapheresis 4 Serious disease or medical condition of the liver, kidneys, another organ, a system or blood 5 Persistent abnormal plasma proteins including monoclonal or polyclonal gammopathy 6 Current or past use of medication that poses an ongoing risk to a recipient of a product manufactured from source plasma 7 History of recurrent fainting associated with the donation of blood or plasma 8 History, signs or symptoms of injectable drug abuse such as skin punctures, scars or sharing needles to inject drugs 9 History, signs or symptoms of AIDS or HIV infection 10 Risk of HIV infection based on sexual practices 11 History, signs or symptoms of a chronic or persistent infection or parasitic disease transmissible by blood 12 History, signs or symptoms of hepatitis, other than hepatitis A 13 Cancer, other than non-melanoma skin cancer or in-situ cervical cancer 14 Risk factor for Creutzfeldt-Jacob disease (CJD) or its variant (vCJD) based on, but not limited to, the receipt of dura mater transplant or a treatment using a human pituitary hormone 15 Positive test result for any transmissible disease agent
- SOR/78-545, s. 1
- SOR/85-1022, s. 3
- SOR/2006-353, s. 1
- Date modified: